Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy

Haematologica. 2019 Feb;104(2):e68-e71. doi: 10.3324/haematol.2018.198812. Epub 2018 Sep 6.

¹ Department of Haematology, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust toby.eyre@ouh.nhs.uk.
² The Ernest and Helen Scott Haematological Research Institute, University of Leicester.
³ Department of Haematology, The Royal Marsden Hospital, London.
⁴ Department of Haematology, Addenbrooke's Hospital NHS Trust, Cambridge.
⁵ Department of Haematology, Nottingham University Hospitals NHS Trust.
⁶ Department of Haematology, Ipswich Hospital.
⁷ Department of Haematology, NHS Tayside, Dundee.
⁸ Department of Haematology, Western Sussex Hospitals NHS Foundation Trust, Worthing.
⁹ Department of Haematology, Churchill Hospital, Oxford University Hospitals NHS Foundation Trust.

No abstract available

Publication types